In our study, the reduced IL-1β cleavage in the sciatic nerve following MP-10 treatment further supported the idea that PDE10A inhibition modulates inflammasome activation in nerve injury, contributing to improved functional recovery and reduced muscle atrophy. The gene discussed is PDE10A; the disease is injury.